On our radar
The global ripples of domestic vaccine suspensions
The United States hit pause this week on its rollout of the Johnson & Johnson vaccine, in a move that could have repercussions for countries with spiralling COVID-19 infections but few vaccine options. The US Centers for Disease Control and Prevention is reviewing the vaccine produced by J&J after six people – from more than 6.8 million doses administered – developed rare blood clots. It’s unclear what caused the blood clots, which can occur naturally (and can also be caused by COVID-19 itself). Soon after, South Africa paused its J&J rollout as a precautionary measure. Several countries previously paused use of the Oxford-AstraZeneca vaccine for similar reasons, though Europe’s drugs regulator and a World Health Organization committee later declared the vaccine safe. The COVAX equity scheme, which is supplying much of the world’s vaccines, is heavily reliant on both vaccines. The precautionary suspensions ar
El-geneina
Gharb-darfur
Sudan
Somalia
Mexico
Afghanistan
United-states
Paris
France-general
France
Mogadishu
Banaadir